Avalo Therapeutics Inc (AVTX) — Capital Reinvestment Ratio
Avalo Therapeutics Inc (AVTX) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($5.73 Million) in capital expenditures ($39.00K). Check AVTX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Avalo Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Avalo Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see AVTX operating cash flow.
Annual Capital Reinvestment Ratio for Avalo Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Avalo Therapeutics Inc from 2017 to 2017. See cash generation quality of Avalo Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.00x | $12.52 Million | $23.32K | — |